Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q3 2019 13F Holders as of 30 Sep 2019
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 18,982,051
- Total 13F value
- $39,859,066
- Share change
- +3,022,908
- SEC-reported price per share
- $2.10
- Number of holders
- 53
- Value change
- +$6,042,313
- Number of buys
- 29
- Number of sells
- 25
- Shares outstanding
- 28,495,649
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2019
Institutions
53
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2019
Previous quarter: Q2 2019
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Jun 2019
13F
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
28%
EMERALD MUTUAL FUND ADVISERS TRUST
8.4%
BlackRock Finance, Inc.
5.5%
VANGUARD GROUP INC
5%
STATE STREET CORP
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
28%
|
$20,165,000
8,098,267 shares
|
— | 30 Jun 2019 |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
Company
|
8.4%
|
$5,927,000
2,380,180 shares
|
— | 30 Jun 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
5.5%
|
$3,869,000
1,553,990 shares
|
— | 30 Jun 2019 |
| VANGUARD GROUP INC |
13F
Company
|
5%
|
$3,521,000
1,413,924 shares
|
— | 30 Jun 2019 |
| STATE STREET CORP |
13F
Company
|
1.2%
|
$877,000
352,320 shares
|
— | 30 Jun 2019 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.1%
|
$760,000
305,420 shares
|
— | 30 Jun 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
53
Shares
18,982,051
Rows available
53
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
48
Q3 2019 holders
53
Holder diff
5
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 value | Q3 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend